Open AccessIs Oral Ribavirin for the Treatment of Respiratory Syncytial Virus in High-risk Hematopoietic Stem Cell Transplant Recipients Really Safe?
Author(s) -
Shilpa R. Jain,
Pakpoom Phoompoung,
Shahid Husain
Publication year - 2019
Publication title -
clinical infectious diseases
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 3.44
H-Index - 336
eISSN - 1537-6591
pISSN - 1058-4838
DOI - 10.1093/cid/ciz376
Subject(s) - ribavirin , medicine , hematopoietic stem cell transplantation , hematopoietic cell , hematopoietic stem cell , respiratory system , virus , virology , stem cell , immunology , intensive care medicine , haematopoiesis , transplantation , hepatitis c virus , biology , genetics
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom